A scientist and colleagues from the University of California San Diego School of Medicine are on to an exciting discovery that could someday lead to new therapeutic options to eradicate Parkinson’s disease symptoms and possibly other neurodegenerative disorders. What have they discovered, and how could it be developed into therapies to save the next generation of Parkinson’s disease patients?
TrialSite News breaks down this exciting update for members of the TrialSite Network.
This story centers around Xiang-Dong Fu, PhD, who recently became extremely excited about the biggest breakthrough in his career, reports the University of California's Heather Buschman, PhD, from UCSD. Dong focuses on the basic biology of RNA and its genetic cousin DNA and associated binding proteins. But a single discovery launched Fu into the field of neuroscience.
What topic did Fu and team study for decades at the University of California San Diego (UCSD)?
The team focused on a protein called PTB. As Ms. Buschman educates the reader in the UC press release, PTB is known for binding RNA and influencing whether a gene is turned “on” or “of” in a cell. Scientists such as Fu often manipulat...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).